Biomarkers in asthma

Anandhi Murugan, Curig Prys-Picard, William Calhoun

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

To date, the best validated, and best performing biomarkers for clinical asthma appear to be measures of inflammation in induced sputum, and measures of ENO. Some trials using ENO appear particularly promising for early clinical use. EBC metrics are at present too inchoate for clinical purposes. However, not all important clinical and research questions can be addressed with sputum, EBC, or ENO metrics, leaving an important place for BAL, bronchial biopsy, and perhaps EBC measurements in the research arena.

Original languageEnglish (US)
Pages (from-to)12-18
Number of pages7
JournalCurrent Opinion in Pulmonary Medicine
Volume15
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Sputum
Asthma
Biomarkers
Dimercaprol
Research
Inflammation
Biopsy

Keywords

  • Asthma
  • Biomarker
  • Phenotype
  • Prediction

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Biomarkers in asthma. / Murugan, Anandhi; Prys-Picard, Curig; Calhoun, William.

In: Current Opinion in Pulmonary Medicine, Vol. 15, No. 1, 01.2009, p. 12-18.

Research output: Contribution to journalArticle

Murugan, Anandhi ; Prys-Picard, Curig ; Calhoun, William. / Biomarkers in asthma. In: Current Opinion in Pulmonary Medicine. 2009 ; Vol. 15, No. 1. pp. 12-18.
@article{f3d164ae918f475d9d6543f4081ed60b,
title = "Biomarkers in asthma",
abstract = "To date, the best validated, and best performing biomarkers for clinical asthma appear to be measures of inflammation in induced sputum, and measures of ENO. Some trials using ENO appear particularly promising for early clinical use. EBC metrics are at present too inchoate for clinical purposes. However, not all important clinical and research questions can be addressed with sputum, EBC, or ENO metrics, leaving an important place for BAL, bronchial biopsy, and perhaps EBC measurements in the research arena.",
keywords = "Asthma, Biomarker, Phenotype, Prediction",
author = "Anandhi Murugan and Curig Prys-Picard and William Calhoun",
year = "2009",
month = "1",
doi = "10.1097/MCP.0b013e32831de235",
language = "English (US)",
volume = "15",
pages = "12--18",
journal = "Current Opinion in Pulmonary Medicine",
issn = "1070-5287",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Biomarkers in asthma

AU - Murugan, Anandhi

AU - Prys-Picard, Curig

AU - Calhoun, William

PY - 2009/1

Y1 - 2009/1

N2 - To date, the best validated, and best performing biomarkers for clinical asthma appear to be measures of inflammation in induced sputum, and measures of ENO. Some trials using ENO appear particularly promising for early clinical use. EBC metrics are at present too inchoate for clinical purposes. However, not all important clinical and research questions can be addressed with sputum, EBC, or ENO metrics, leaving an important place for BAL, bronchial biopsy, and perhaps EBC measurements in the research arena.

AB - To date, the best validated, and best performing biomarkers for clinical asthma appear to be measures of inflammation in induced sputum, and measures of ENO. Some trials using ENO appear particularly promising for early clinical use. EBC metrics are at present too inchoate for clinical purposes. However, not all important clinical and research questions can be addressed with sputum, EBC, or ENO metrics, leaving an important place for BAL, bronchial biopsy, and perhaps EBC measurements in the research arena.

KW - Asthma

KW - Biomarker

KW - Phenotype

KW - Prediction

UR - http://www.scopus.com/inward/record.url?scp=58149247977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149247977&partnerID=8YFLogxK

U2 - 10.1097/MCP.0b013e32831de235

DO - 10.1097/MCP.0b013e32831de235

M3 - Article

C2 - 19077700

AN - SCOPUS:58149247977

VL - 15

SP - 12

EP - 18

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

SN - 1070-5287

IS - 1

ER -